COMMUNIQUÉS West-GlobeNewswire

Braveheart Bio to Participate in Cantor Global Healthcare Conference
01/09/2026
SAN FRANCISCO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Braveheart Bio, Inc. (Nasdaq: BRVE), a clinical-stage biopharmaceutical company developing next-generation therapeutics for hypertrophic cardiomyopathy (HCM) and other [...]
Tarsus to Participate in Upcoming Investor Conferences
01/09/2026
IRVINE, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to attend the following upcoming investor conferences: Wells Fargo 21 st Annual [...]
Teva to Present at Morgan Stanley, J.P. Morgan and BofA Investor Conferences in September
01/09/2026
TEL AVIV, Israel, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at three upcoming investor [...]
Cellectis annonce sa participation à plusieurs conférences investisseurs
01/09/2026
NEW YORK, 01 sept. 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS ; Nasdaq : CLLS), société de biotechnologie de stade clinique, qui utilise sa plateforme pionnière d'édition de génome pour développer des [...]
Cellectis Announces Participation in Upcoming Investor Conferences
01/09/2026
NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving [...]
STERIS to Present at the Morgan Stanley Healthcare Conference
01/09/2026
Dublin, Ireland, Sept. 01, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will participate in the Morgan Stanley Healthcare Conference in New York City on Tuesday, [...]
aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis
01/09/2026
Company anticipates response from FDA by mid-September 2026 on protocol submitted for planned Phase 3 study of efzofitimod in patients with pulmonary sarcoidosis with restrictive lung disease. SAN DIEGO, Sept. 01, 2026 [...]
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September
01/09/2026
CAMBRIDGE, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients [...]
Research Team Wins Heinz Maurer Award for Linking Bacterium to Eczema Barrier Failure
01/09/2026
Using Lipotype's lipidomics platform, scientists map how Staphylococcus hominis affects the skin's lipid environment in atopic dermatitis, opening promising pathways for eczema treatment DRESDEN, Germany, Sept. 01, 2026 [...]
Haypp Group to Participate in Key Global Tobacco and Nicotine Conferences This Fall
01/09/2026
Washington, D.C, USA, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Haypp Group , parent company of U.S. online nicotine pouch retailers Nicokick.com and Northerner.com , today announced that its leadership will participate in [...]
Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference
01/09/2026
BRIDGEWATER N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Alan Bash, interim Chief Executive Officer, will [...]
Voyager to Present at Upcoming Investor Conferences
01/09/2026
LEXINGTON, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced that the company [...]
Nurix Therapeutics to Participate in Upcoming September Investor Conferences
01/09/2026
BRISBANE, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein [...]
CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth
01/09/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept. 01, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“ CDT ” or the “ Company ”) today announced the appointment of James Bligh, co-founder of Conduit [...]
Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter
01/09/2026
Oak Ridge, TN, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today provides a mid-year corporate and financial update in a Letter to [...]
Kinjirushi Introduces Hexaraphane and Research Into Its Potential Brain Health Benefits to North America
01/09/2026
Japanese wasabi specialist brings decades of expertise to North America as research explores the relationship between wasabi-derived compounds, cognitive function and healthy aging TORRANCE, Calif., Sept. 01, 2026 ( [...]
Sofwave to Participate in the Wells Fargo 21st Annual Healthcare Conference
01/09/2026
SAN CLEMENTE, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today [...]
ProMIS Neurosciences to Participate in Upcoming Conferences and Events in September
01/09/2026
CAMBRIDGE, Mass, Sept. 01, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in [...]
Belite Bio to Participate in Four Upcoming Investor Conferences
01/09/2026
SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Belite Bio , Inc (NASDAQ: BLTE) (“Belite Bio ® ” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative [...]

Pages